gayuba

Bearberry (Arctostaphylos uva-ursi): A Comprehensive Reference

1. Identity: Botanical Name, Taxonomy, and Natural Source

Arctostaphylos uva-ursi is a plant species of the genus Arctostaphylos, widely distributed across circumboreal regions of the subarctic Northern Hemisphere. Its specific epithet uva-ursi means "grape of the bear" in Latin, similar to the meaning of the generic epithet Arctostaphylos (Greek for "bear grapes"). The plant belongs to the family Ericaceae.

Arctostaphylos uva-ursi, known by a large number of common names including common bearberry and kinnikinnick, is an extremely winter hardy, creeping, slow-growing, prostrate, woody evergreen shrub that typically grows to 6–12 inches tall but spreads over time by flexible branching (roots at the nodes) to 3–6 feet wide or more. The flowers are white to pink and the fruit is a red berry.

Numerous common names exist, depending on region, such as mealberry, sandberry, mountain-box, fox-plum, hog-crawberry, and barren myrtle. The name "kinnikinnick" derives from an Algonquian word. Kinnikinnick (from the Unami language for smoking "mixture") is a common name in Canada and the United States.

This is a circumpolar ground-hugger which is native throughout the northern parts of North America, Europe, and Asia. In North America, it is typically found in a variety of locations from Alaska to Newfoundland south through Canada to Virginia, Illinois, South Dakota, New Mexico, and central California, in a variety of habitats typically including gravelly and/or sandy exposed sites, dry/rocky slopes/outcrops, forest margins, and forest clearings.

The official herbal material derived from this plant is known in pharmacopoeial Latin as Uvae ursi folium (bearberry leaf). According to the European Pharmacopoeia, the arbutin content in the dried leaf of A. uva-ursi must be at least 7% (wt/wt). The species is endangered and protected in many European countries.

Common Dosage Forms and Preparations

Bearberry supplements are available over the counter (OTC) as dried leaves, powder, or liquid extracts that can be taken orally. The European Medicines Agency (EMA) HMPC conclusions cover bearberry leaf preparations obtained by drying and comminuting or powdering the leaves, or by extracting compounds using a solvent (such as ethanol or water) to form a liquid extract; the solvent may then be evaporated to obtain a dry extract. Herbal medicines containing these preparations are usually available as herbal tea to be consumed and in solid (tablet or capsule) forms.

2. Traditional and Historical Use

Native American and Indigenous Peoples of North America

Bearberry leaves have been used by the indigenous people of America for centuries to treat urinary tract infections. Native Americans ate the berries, smoked the leaves, and used the leaves in medicinal teas, as an eyewash, hair wash, and mouthwash, and especially for bladder and kidney issues.

Dried bearberry leaves are the main component in many traditional North American Native smoking mixes, known collectively as "kinnikinnick" (Algonquin for "smoking mixture"), used especially among western First Nations, often including other herbs and sometimes tobacco. Native Americans used bearberry, or kinnikinnick as they called it, in their ceremonial pipe in place of tobacco. The Arikaras cultivated sacred tobacco and mixed it with bearberry dried leaves and the dried inner bark of red dogwood.

Some Native American tribes used an infusion of the stems of bearberry and blueberry as a way to prevent miscarriage, and to aid a woman's recovery after childbirth.

European Traditions

In northern Europe and Eurasia, bearberry tea has been a traditional herbal treatment for hundreds of years. Welsh herbalists first documented bearberry in the mid-13th century. The German pharmacist Gerhardt first recommended it for medicinal use in 1763.

Bearberry has been traditionally used in herbal medicine as a mild diuretic to help relieve symptoms associated with minor urinary tract infections, such as burning sensation and/or frequent urination. It is a traditional bladder treatment used in European folk medicine.

Uva ursi is approved for treatment of lower urinary tract infection by the German Commission E; the active component is believed to be arbutin (arbutoside), which is hydrolyzed releasing hydroquinone.

Broader Traditional Applications

Bearberry has been used since the 2nd century, with cultures worldwide recommending the herb as a treatment for nephritis, kidney stones, or chronic cystitis. The leaves, which contain astringent tannins, arbutin, and hydroquinone, are traditionally used to make poultices, salves, and other topical preparations. Indigenous peoples also used the plant to make yellow dye.

3. Key Constituents and Active Compounds

Primary Phytochemicals

The plant contains a steroid (sitosterol) and triterpenoids such as amyrin, betulinic acid, lupeol, oleanolic acid, taraxenol, ursolic acid, and uvaol. The main constituent is a glucoside called arbutin.

Methylarbutin (4%), glycosides arbutin (5 to 15%), and free aglycones are abundant in the leaves, whereas tannic acid, ursolic acid, gallotannins, gallic acid, syringic acid, p-coumaric acid, flavonoids, and galloylarbutin are present in lesser amounts.

The chemical profile of bearberry leaves is also characterized by the presence of penta-O-galloyl-β-d-glucose, hyperoside, corilagin, and picein, as well as glycosidic forms of flavonoids — quercetin, kaempferol, and myricetin glycosides.

Bearberry leaf extracts include 312 mg/g of polyphenolic compounds and 90.42 mmol of Trolox equivalents/g dry weight. Bearberry extract is a common natural antioxidant in food systems due to its high phenolic content.

Arbutin: Structure and Biochemistry

Arbutin is a compound in which one molecule of D-glucose is bound to hydroquinone. D-glucose exists in α, β, or γ-anomeric form in aqueous solution, with β-anomer being the dominant form. β-Arbutin, in which the β-anomer of D-glucose is bound to hydroquinone, is mainly found in plants such as bearberry.

The synthetic α-isomer (alpha-arbutin) is mainly used as a skin brightening agent, while β-arbutin occurs naturally — for instance, in bearberry — and is used in drugs for treatment of lower urinary tract infections and as a food supplement.

The most representative constituent of the herbal drug is arbutin, which is rapidly absorbed in the small intestine and undergoes hepatic conjugation to form hydroquinone (HQ) conjugates.

Tannins

Polyphenols such as tannins are particularly high in bearberry. These include gallotannins, catechin, and corilagin. Phenolic acids including gallic acid, p-coumaric acid, and syringic acid are also present. One group of tannins — the reddish-brown "condensed tannins" — are procyanidins, which can reduce inflammation and oxidative damage.

4. Established Mechanisms of Action

Urinary Antiseptic Mechanism (Arbutin → Hydroquinone)

Arbutin is hydrolyzed in the stomach, releasing hydroquinone, which is absorbed and metabolized to the glucuronide in the liver; this conjugate is then rapidly excreted in the urine, where free hydroquinone is released (if urine is alkaline) and acts locally as an antiseptic.

Approximately 65% of arbutin is converted into hydroquinone. The mechanism of action of hydroquinone is largely related to destroying the bacterial wall and causing the death of bacteria.

Hydroquinone is then metabolized to glucuronate and sulfate esters, which are excreted in the urine and are responsible for the antiseptic and astringent actions in the urinary tract.

Because uva-ursi's antimicrobial activity can be blocked in acidic urine, ingestion of animal products or other foods known to acidify the urine should be reduced with its use. Administration of sodium or potassium bicarbonate may help alkalinize the urine. Urinary pH should be greater than 7 for antimicrobial effectiveness.

Anti-Adhesion and Biofilm Disruption

Arbutin in bearberry is a key bioactive compound that exhibits potent anti-adhesive and biofilm-disrupting properties, offering promising adjunctive strategies for preventing recurrent urinary tract infections. These compounds work synergistically to reduce bacterial adhesion to urinary tract tissues and modulate inflammatory pathways in the bladder and kidneys.

Tyrosinase Inhibition and Skin Depigmentation

The mode of action of arbutin for skin depigmentation appears to be by inhibition of melanosomal tyrosinase and DHICA polymerase activities at noncytotoxic concentrations, rather than by suppression of the synthesis and expression of this enzyme. It is thought that the activity of arbutin is driven by the structural homologies it shares with the substrate tyrosine, which leads to competitive inhibition of the catalytic function of tyrosinase.

β-Arbutin acts as an enzyme inhibitor of cellular tyrosinase by inactivating it. Tyrosinase is an enzyme needed in melanin synthesis in the melanocyte. By reducing the activity of tyrosinase, β-arbutin reduces the synthesis of melanin, leading to a lighter skin tone and the diminished appearance of hyperpigmentation.

Antioxidant Activity

Bearberry has been proposed as a natural antioxidant additive due to the high contents of phenolic compounds in its leaves. Studies on the antioxidant properties of arbutin are emerging, and these antioxidant properties are proposed to contribute to the skin depigmenting action of arbutin.

5. Scientific Evidence by Area of Use

5.1 Urinary Tract Infections and Lower Urinary Tract Symptoms

Regulatory status and traditional-use designation: The EMA HMPC conclusions on the use of bearberry leaf medicines for lower urinary tract infections are based on their "traditional use." The European Medicines Agency (EMA) concluded that, based on its traditional use, the effectiveness of uva-ursi extracts was plausible and that its use was safe. However, the EMA noted that clinical studies allowing a final assessment of the potency and safety of β-arbutin were still lacking.

Key clinical study — double-blind recurrence prevention trial: Bearberry leaves and preparations made from them have significant antibacterial activity (especially against E. coli) and astringent activity due to arbutin content and diuretic properties. In a double-blind study of 57 women, five of twenty-seven women had a recurrence in the placebo group, while none of thirty women had a recurrence in the uva-ursi group after 1 year. This result, while encouraging, derives from a single relatively small trial, limiting generalizability.

Pharmacokinetic clinical study: In 16 healthy volunteers given arbutin either as tea made from uva-ursi leaves or as an extract prepared as tablets, hydroquinone glucuronide and sulfate were rapidly detected in urine with lesser amounts of free hydroquinone in all subjects regardless of the ingested form of uva-ursi. Hydroquinone glucuronide and sulfate were detected in urine within 2–6 hours of ingestion of a single 150 mL preparation of tea using bearberry leaves.

Ongoing comparative clinical trial (BRUMI): The doses of the study drugs (fosfomycin trometamol and bearberry leaf extract) were chosen based on international guidelines and the European Union herbal monograph on Arctostaphylos uva-ursi folium. This was described as the first randomised controlled trial to examine the efficacy of bearberry in the treatment of uncomplicated cystitis, with efficacy compared to fosfomycin, a first-line drug, in a multicentre, prospective, randomised, non-inferiority design. The BRUMI trial enrolled 504 patients comparing bearberry tablets against fosfomycin antibiotic treatment, using a non-inferiority margin of 14% for symptom improvement. A separate study with 430 patients examined whether bearberry treatment could reduce antibiotic use over 28 days.

Overall evidence quality: Bearberry is possibly effective for mild urinary tract inflammation, but there is little scientific evidence to support any of its other uses. While traditional use and laboratory studies support antimicrobial activity, well-designed clinical trials directly comparing bearberry to standard antibiotic therapy remain insufficient to establish definitive therapeutic equivalence.

5.2 Skin Depigmentation and Hyperpigmentation

Extracts from the leaves have been used in cosmetic preparations as skin-whitening agents but may cause irritation and discolouration of the skin.

The skin lightening efficacy of arbutin alone or in combination with other active ingredients has been clinically evaluated. Combined therapy with arbutin and laser could give enhanced depigmenting efficacy.

Trials on a pigmented guinea pig model have shown the effectiveness and rapidity of deoxyarbutin (a derivative) in reducing skin hyperpigmentation. These results were confirmed in human clinical trials 12 weeks long. The bleaching effect is reversible and lacks skin irritation.

β-Arbutin is generally considered safe for topical application in cosmetic products. However, its usage concentrations in the EU are restricted by the European Commission Scientific Committee on Consumer Safety to 7% in facial creams, provided the contamination of hydroquinone remains below 1 ppm.

Evidence for topical arbutin in skin depigmentation is primarily from in vitro cell culture work and limited clinical trials. Direct human clinical evidence specifically for bearberry-derived arbutin preparations — as distinct from isolated or synthetic arbutin — remains limited.

5.3 Antioxidant Activity

Bearberry's antioxidant activity has been extensively characterized in laboratory settings. Bearberry leaf extracts include 312 mg/g of polyphenolic compounds and 90.42 mmol of Trolox equivalents/g dry weight. These values indicate high in vitro antioxidant capacity attributable to the phenolic fraction. No controlled human clinical trials measuring clinical antioxidant outcomes from bearberry consumption have been identified in the reviewed literature.

5.4 Antimicrobial Activity (In Vitro)

Bearberry arbutin has been found to exert anti-adhesive, antimicrobial, anti-inflammatory, and biofilm-inhibitory properties in laboratory studies. Bearberry leaves and preparations made from them have significant antibacterial activity, especially against E. coli. However, the majority of antimicrobial data originates from in vitro studies; clinical translation requires further investigation.

6. Body Systems and Health Areas Associated with Bearberry

• Urinary / Genitourinary System: For many years, leaves of this plant have been used in traditional medicine as a diuretic, antimicrobial, and anti-inflammatory agent for various diseases of the urogenital tract.
• Integumentary System (Skin): Arbutin is defined as a herbal extract that inhibits tyrosine activity to prevent melanosome maturation, with effects that vary by dosage. It is used topically to reduce pigmentation, particularly in conditions like melasma.
• Digestive System: Bearberry may also be useful for those experiencing poor function in the digestive system relating to low tone of the stomach and bowels, which may present as loose stools or chronic diarrhoea.
• Respiratory System: It also has an anti-catarrhal effect on the lower respiratory system, which may be of use for acute cases of bronchitis to help reduce phlegmatic secretions in the lungs. This use is based on traditional application and lacks formal clinical investigation.

7. Dosage Forms and Dosages Reported in Studies and Monographs

The WHO Monographs on Selected Medicinal Plants lists doses of 3 g in 150 mL as an infusion or cold macerate, 3 to 4 times daily; 400 to 840 mg of hydroquinone derivatives; or other preparations accordingly calculated as arbutin.

Methods of preparation include dry, powder, non-standardised extracts (dry extract, tincture, fluid extract, decoction, infusion): 0.3–1.33 grams of dried leaves, 2 to 3 times per day. (Health Canada Natural Health Products Directorate monograph.)

A therapeutic recommended human daily dose of bearberry leaf extract (420 mg hydroquinone derivatives calculated as anhydrous arbutin) liberates free hydroquinone in urine at a maximum exposure level of 11 µg/kg body weight per day.

In the BRUMI clinical trial, the bearberry tablet used was Urzinol, containing a dry extract of Arctostaphylos uva-ursi leaf (DER 3.5–5.5:1, extracting solvent 60% v/v ethanol), 238.7–297.5 mg extract per tablet, corresponding to 70 mg hydroquinone derivatives expressed as anhydrous arbutin.

The EMA herbal monograph states the preparation should not be used for more than one week. These medicines should only be used in adult women according to the EMA HMPC conclusions.

8. Safety Considerations and Drug Interactions

General Safety Profile

There is no direct evidence, regarding human data, supporting the fact that free hydroquinone causes convulsion, hepatotoxicity, nephrotoxicity, or promotion of tumors in humans. Free hydroquinone had no activity promoting pancreatic, bladder, stomach, or liver carcinogenesis. In conclusion, under the recommended use conditions, Uvae ursi folium is a safe therapeutic option for treating lower urinary tract infections.

Treatment with extracts of uva ursi has not been specifically linked to serum aminotransferase elevations or to instances of clinically apparent acute liver injury. Uva ursi has not been linked to serum enzyme elevations during therapy, although there have been few prospective studies of its adverse effects on laboratory test results. There have been no convincing published instances of clinically apparent liver injury attributed to uva ursi. The NIH LiverTox database assigns it a likelihood score of E (unlikely cause of clinically apparent liver injury).

Reports of carcinogenicity of hydroquinone after prolonged administration of high doses to rats or mice raise a question about the long-term safety of A. uva-ursi and other medicinal herbs that contain substantial amounts of arbutin. These concerns are noted in the context of animal data at high doses, not at therapeutic human doses.

Common Adverse Effects

Common side effects include nausea, vomiting, or an upset stomach. The urine of patients taking bearberry can darken on standing. A side effect of bearberry is that it can rarely turn the urine brighter yellow or green, though this is not dangerous.

Ocular Toxicity: Case Report

A 57-year-old woman who ingested uva-ursi tea preparations several times daily for 3 years developed "bull's-eye" maculopathy, which is typical of hydroxychloroquine macular injury, suggesting that hydroquinone from uva-ursi, which inhibits tyrosine kinase and melanin synthesis, can cause macular injury as well. The authors suggested that the effect was due to impaired melanin synthesis. This remains an isolated published case report (Wang & Del Priore, Am J Ophthalmol, 2004).

Duration Limitations

Bearberry leaf preparations should only be used after serious conditions have been excluded by a doctor. These medicines should only be used in adult women. They should not be taken for longer than one week, and if symptoms last for more than four days or worsen during the use of the medicine, a doctor or qualified healthcare professional should be consulted.

Contraindications

Bearberry is contraindicated for use during pregnancy or lactation. Using uva ursi during pregnancy is likely unsafe because it might start labor. Bearberry should not be used by young children below the age of 12, due to reports of liver toxicity when taken in larger doses. Uva ursi is generally not recommended for young children, pregnant or nursing women, and individuals with severe liver or kidney disease.

Drug and Substance Interactions

There are no major interactions known for bearberry, although medications that acidify the urine may be inactivated by bearberry and, therefore, concurrent use should be avoided.

According to Medscape drug interaction data, alkalinizing agents including acetazolamide, aluminum hydroxide, calcium carbonate, and sodium bicarbonate will increase the level or effect of bearberry by passive renal tubular reabsorption in basic urine — monitor with caution. Conversely, agents that acidify the urine will reduce bearberry's antimicrobial activity by preventing hydroquinone release.

Some herbal agents, such as A. uva-ursi (bearberry), contain hydroquinone derivatives like arbutin, which may pose a risk of hepatotoxicity or nephrotoxicity if used in excessive or prolonged doses.

Cosmetic Safety Limits

The use of arbutin causes dermatitis rarely, and caution is recommended for the use of arbutin-containing products, especially from the viewpoint that hydroquinone may be generated during product use. The European Union's Scientific Committee on Consumer Safety has evaluated alpha arbutin for cosmetic use and confirmed its safety at concentrations up to 2% in face products.

References

• Plant Extracts and Natural Compounds for the Treatment of Urinary Tract Infections in Women — PMC, 2025
• Natural therapeutics for urinary tract infections — a review, PMC, 2020
• BRUMI Protocol: Bearberry in the treatment of acute uncomplicated cystitis — PMC, 2022
• Urinary Excretion and Metabolism of Arbutin after Oral Administration of Arctostaphylos uvae ursi Extract — PubMed, 2002
• Risk assessment of free hydroquinone derived from Arctostaphylos Uva-ursi folium herbal preparations — PubMed, 2013
• Uva Ursi — LiverTox® — NCBI Bookshelf
• Arbutin as a Skin Depigmenting Agent with Antimelanogenic and Antioxidant Properties — PMC, 2021
• Variation in Population and Solvents as Factors Determining the Chemical Composition and Antioxidant Potential of Arctostaphylos uva-ursi — PMC, 2022
• Chemical Characteristics and Antioxidant Activity of Arctostaphylos uva-ursi at the Southern Border of the Geographical Range — PMC, 2022
• Quantification of Arbutin in Cosmetics, Drugs and Food Supplements — PMC, 2022
• Uvae ursi folium — European Medicines Agency (EMA)
• Bearberry Leaf — EMA Summary for the Public
• EU Herbal Monograph on Arctostaphylos uva-ursi folium, Revision 2 — EMA
• Bearberry — Health Canada Natural Health Products Ingredients Database
• Bearberry in the Treatment of Cystitis (BRUMI) — ClinicalTrials.gov
• Arctostaphylos Uva-Ursi — ScienceDirect Topics (Agricultural and Biological Sciences)
• Arbutin — ScienceDirect Topics (Medicine and Dentistry)
• Arctostaphylos uva-ursi — Wikipedia
• Arbutin — Wikipedia
• Uva Ursi Uses, Benefits & Dosage — Drugs.com
• Bearberry: UTI Uses, Benefits, Side Effects, Warnings — MedicineNet
• Bearberry Drug Interactions — Medscape Reference
• Arctostaphylos uva-ursi — Missouri Botanical Garden Plant Finder
• Phenolic Compounds Content and Genetic Diversity Across the Natural Distribution Range of Bearberry in the Iberian Peninsula — PMC, 2020